Course Description
Malignant Hyperthermia: Perioperative Crisis
Sponsored By:
Your fee for this course is generously paid for by Revonto TM (dantrolene sodium for injection). Education is the key to preparing for a potential MH crisis.
Author:
Purpose:
It is estimated that approximately 1 case in every 20,000 to 50,000 cases that a patient will have a malignant hyperthermia (MH) crisis. The event is even more common in children. If the MH crisis is not identified and begun to be treated during the first few minutes, the patient can suffer serious harm or death. This course reviews MH etiology, signs and symptoms, and treatment. The four roles play by perioperative nurses during a MH crisis are also addressed. OR nurses should review MH crisis yearly to be able to respond more effectively during this life-threatening crisis.
This course expires on July 31, 2012.
The approval number for this course is: #05310.
This course expires on July 31, 2012.
The approval number for this course is: #05310.
Objectives
- Examine parameters of malignant hyperthermia
- Illustrate treatment of malignant hyperthermia
Disclosures:
Requirements for Completion: Click Here
Conflict Of interest:
There is no conflict of interest noted for this course.
Sponsorship/Commercial Support:
A sponsorship has been given by US WorldMeds. They did not participate in the development of this course.
Nonendorsement of Products:
Approval for this activity refers only to continuing nursing education activity and does not imply that there is real or implied endorsement of any product, service, or company referred to in this activity nor of any company subsidizing costs related to the activity.
Off Label Use:
There is no use of off label products in this presentation.
Accreditation:
This continuing nursing education activity was approved by the Tennessee Nurses Association, an accredited approver by the American Nurses Credentialing Center's Commission on Accreditation.
